XBiotech Inc. (XBIT)
NASDAQ: XBIT · Real-Time Price · USD
2.510
-0.020 (-0.79%)
At close: Jan 7, 2026, 4:00 PM EST
2.560
+0.050 (1.99%)
After-hours: Jan 7, 2026, 6:50 PM EST
XBiotech Market Cap
XBiotech has a market cap or net worth of $76.52 million as of January 7, 2026. Its market cap has decreased by -60.41% in one year.
Market Cap
76.52M
Enterprise Value
-70.23M
1-Year Change
-60.41%
Ranking
Category
Stock Price
$2.51
Market Cap Chart
Since April 15, 2015, XBiotech's market cap has decreased from $737.40M to $76.52M, a decrease of -89.62%. That is a compound annual growth rate of -19.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 7, 2026 | 76.50M | 4.94% |
| Dec 31, 2025 | 72.90M | -39.45% |
| Dec 31, 2024 | 120.40M | -1.07% |
| Dec 29, 2023 | 121.70M | 13.95% |
| Dec 30, 2022 | 106.80M | -68.43% |
| Dec 31, 2021 | 338.30M | -26.12% |
| Dec 31, 2020 | 457.90M | -40.29% |
| Dec 31, 2019 | 766.90M | 321.37% |
| Dec 31, 2018 | 182.00M | 30.37% |
| Dec 29, 2017 | 139.60M | -57.50% |
| Dec 30, 2016 | 328.50M | -6.09% |
| Dec 31, 2015 | 349.80M | -52.56% |
| Apr 15, 2015 | 737.40M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 950.47B |
| Johnson & Johnson | 494.77B |
| AbbVie | 395.81B |
| UnitedHealth Group | 317.97B |
| AstraZeneca | 293.89B |
| Merck & Co. | 271.07B |
| Novartis AG | 268.87B |
| Novo Nordisk | 253.02B |